On the surface, it seemed like a good case. Sandoz Inc., Lupin Pharmaceuticals Inc. and several other generic drugmakers challenged a 2010 patent on Allergan's Lumigan eye drops for treating glaucoma.
The Food and Drug Administration has approved Amneal’s bimatoprost ophthalmic solution 0.01% (2.5 ml, 5 ml and 7.5 ml), which is the generic of Allergan’s Lumigan. Bimatoprost ophthalmic solution 0.01 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback